洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR2400094247】Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial

查看原文

立即下载

基本信息

登记号

ChiCTR2400094247

试验状态

尚未开始

药物名称

药物类型

规范名称

首次公示信息日的期

2024-12-19

临床申请受理号

靶点

适应症

chronic pain

试验通俗题目

Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial

试验专业题目

Efficacy of Online Gamified Pain Management for Adults with Chronic Pain in Mainland China: A Randomized Control Trial

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

121000

联系人通讯地址

请登录查看

临床试验信息

试验目的

The study aims to develop and examine the effectiveness of the online gamified pain management (GPM) for chronic pain among adults in mainland China. To this end, the objectives will be: 1) examine the effects of the GPM intervention on the levels of pain intensity, pain interference, psychological outcomes and quality of life among adults in mainland China. 2) identify the relationships between the effects of the intervention and socio-demographic factors. 3) explore the perceptions, attitudes and experiences after participating in the intervention.

试验分类

请登录查看

试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

Eligible participants will be randomly assigned to either the GPM intervention (experimental group) or the online handout intervention (control group) using an online randomizer (True Random Number Service) with a 1:1 ratio by a blinded student member who is not involved in study design, assessment or the intervention delivery.

盲法

All participants will be blinded to their group allocation until the intervention delivered.

试验项目经费来源

None

试验范围

目标入组人数

110

实际入组人数

第一例入组时间

2024-12-31

试验终止时间

2025-06-30

是否属于一致性

入选标准

1) Aged older than 18 years old 2) Able to read and understand the Mandarin Chinese language 3) Owners of smartphones with internet access 4) Have a previously diagnosed chronic non-cancer pain condition lasting more than three months (Treede et al., 2019) 5) Report a score of ≥2 on the VAS scale；

排除标准

1) Patients with associated pathologies that make it impossible to perform physical exercise (myopathies, neurological diseases, cardiac disease, pregnancy, pulmonary diseases, infection and fracture) 2) Individuals undergoing surgery or invasive treatments in the last three months 3) Concurrent participation (or participation within the preceding 3 months) in a supervised exercise programme or multidisciplinary treatment；

研究者信息

研究负责人姓名

请登录查看

试验机构

Hong Kong Metropolitan University

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

999077

联系人通讯地址